Progress in immunotherapy of myelin oligodendrocyte glycoprotein-IgG associated disorders / 中华神经科杂志
Chinese Journal of Neurology
;
(12): 390-395, 2020.
Artigo
em Chinês
| WPRIM
| ID: wpr-870808
ABSTRACT
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) are newly recognized immune-mediated inflammatory demyelinating diseases of the central nervous system. The diseases can be manifested as a single-phase or recurrent course, recurrent episodes of which can leave serious neurological dysfunction, and control of acute attacks and prevention of recurrence is the focus of treatment, including steroids, immunosuppressants and biological agents. This article will review the progress of immunotherapy for MOGAD.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Neurology
Ano de publicação:
2020
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS